MIT researchers develop hydrogel patch to treat tumors post-surgery.
Moving from battlefield medicine to train humanitarian doctors.
Clones of Dolly the sheep show no signs of premature aging.
Using 3-D imaging, researchers find evidence of earliest human cancer in a 1.7-million-yearr-old bone.
AI will help data-driven medicine reach a new frontier by streamlining genomics.
There are more reasons to get the flu vaccine; new study shows it lowers risk of cardiovascular disease in diabetic patients.
Friedreich’s ataxia “family reunion” driving a movement for rare disease research.
Dust off those old 80′s tapes. New research proves exercise keeps DNA young.
You’re getting very sleepy… Stanford scientists uncover what happens in minds of hypnotized subjects.
Scientists find a whole new class of antimicrobials inside noses.
GSK and Google develop implantable devices to tackle diabetes.
“We can tell patients there’s real hope they can live for years—which is a game-changer.”
Could we already hold the key to stopping Zika? Researchers found that 24 FDA-approved drugs have demonstrated the potential to block Zika from infecting human cells. While the drugs haven’t been screened for their ability to rid cells of an existing infection, researchers hope that these treatments can be used in tandem with vaccines to stop the spread of Zika.
A race of superhumans? Most Americans aren’t so keen on biological enhancements.
Hospitals and EMS are working together and sharing data to improve response time for heart-attack victims.
Researchers are taking a genome-wide approach to depression.
Cell therapy, pioneered in part by researchers at Memorial Sloan Kettering Cancer Center, takes T-cells from the patients’ blood and genetically engineers them to find and destroy cancer. After being multiplied in the laboratory, the cells are put back into the patient’s blood stream where just one of the “serial killer” cells can destroy up to 100,000 cancer cells. Researchers feel they are nearing a breakthrough to apply this across cancers.